The role of imaging in hepatocellular carcinoma: The present and future

17Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Imaging plays an important role in diagnosis and management of patients with hepatocellular carcinoma (HCC). Although ultrasound is the main surveillance imaging tool for HCC, dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are used primarily for diagnosis and staging of HCC. Recent advances in both CT and MRI technology have led to a decrease in ionizing radiation exposure and improved capabilities for evaluation of HCC, including, dynamic contrast-enhanced CT and MRI, perfusion CT and MRI, dual-energy CT, radiation dose reduction strategies, diffusion-weighted imaging, MR elastography, iron and fat quantification, and intravenous hepatobiliary contrast agents. © 2013 by Lippincott Williams & Wilkins.

Cite

CITATION STYLE

APA

Davarpanah, A. H., & Weinreb, J. C. (2013). The role of imaging in hepatocellular carcinoma: The present and future. In Journal of Clinical Gastroenterology (Vol. 47). https://doi.org/10.1097/MCG.0b013e31827f0d3d

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free